Michael Kranda has joined Vulcan, the investment company for the assets of Microsoft co-founder Paul Allen, to direct life sciences investment. Prior to joining Vulcan, Kranda was CEO of Oxford Glycosciences, which was acquired by UK biotech firm Celltech in June. Prior to that, he was president, COO, and director at Immunex.
Michael Kranda, Paul Allen
Oct 27, 2003